Crestchem Limited (BOM:526269)
India · Delayed Price · Currency is INR 124.00
+2.40 (1.97%)
At close: May 29, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 408 million as of June 1, 2026. Its market cap has decreased by -33.66% in one year.
Market Cap
408.00M
Enterprise Value
397.54M
Revenue
266.14M
Ranking
n/a
PE Ratio
18.33
Stock Price
124.00
Market Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 408.00M, an increase of 1,206.44%. That is a compound annual growth rate of 20.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 408.00M | 20.94% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Resonance Specialties | 1.46B |
| Smruthi Organics | 1.41B |
| Tyche Industries | 1.40B |
| Krebs Biochemicals & Industries | 1.39B |
| Bacil Pharma | 718.08M |
| Vasundhara Rasayans | 473.23M |
| Alfavision Overseas (India) | 288.78M |
| Venmax Drugs and Pharmaceuticals | 277.99M |